• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

旁路移植物开发中爆破压力测量的关键参数高度依赖于所使用的方法。

Critical parameter of burst pressure measurement in development of bypass grafts is highly dependent on methodology used.

作者信息

Sarkar Sandip, Hillery Claire, Seifalian Alexander, Hamilton George

机构信息

Biomaterials & Tissue Engineering Centre (BTEC), Academic Division of Surgical and Interventional Sciences, Royal Free and University College Medical School, University College London, London, United Kingdom.

出版信息

J Vasc Surg. 2006 Oct;44(4):846-52. doi: 10.1016/j.jvs.2006.07.023.

DOI:10.1016/j.jvs.2006.07.023
PMID:17012007
Abstract

BACKGROUND

Because of the low patency rate of currently available vascular bypass grafts, researchers are working towards the development of alternative bypass grafts, ranging from synthetic prostheses to wholly biologic living grafts. The philosophy of measurement required by regulatory agencies such as the United States Food and Drug Administration (FDA) as well as to gain the Conformité Européene (CE) mark is to test above and beyond the limits that would be expected physiologically. The critical parameter of burst pressure is needed for Conformité Européene (CE) mark or United States Food and Drug Administration (FDA) approval before clinical trials can proceed. An accurate measurement of burst pressure in potential porous vascular bypass grafts is, therefore, of utmost importance to ensure adequate strength on implantation in animals and subsequent clinical use. A wide range of methods to measure burst pressure have been used. We tested the burst pressure of a new polyurethane-based nanocomposite vascular prosthesis by using different methods to assess whether the method used affected the results.

METHODS

Water was infused at flow rates of 0.2, 50, and 100 mL/min through a syringe pump into latex sleeve-lined porous prostheses manufactured from a poly(carbonate-urea)urethane nanocomposite incorporating silsesquioxane. At the lowest infusion rate, the inflation was done with and without a nonporous inner lining sleeve. A pressure transducer was used to record the peak pressure achieved.

RESULTS

Using a nonporous sleeve resulted in a higher burst pressure (428 mm Hg vs 341 mm Hg) at a flow rate of 0.2 mL/min. A lower infusion rate (0.2 mL/min) produced a lower burst pressure than 50 mL/min (428 mm Hg vs 451 mm Hg). No significant difference was found in burst pressure using infusion rates of 50 mL/min and 100 mL/min.

CONCLUSIONS

The use of a nonporous sleeve removes the potential weakness presented by the pores themselves. A continuous high infusion rate consistently overestimates burst pressure. These methods may not reflect the physiologic state. Care needs to be taken in interpretation of methodology for burst pressure measurement, and the rate of infusion should be stated in any description of the method.

CLINICAL RELEVANCE

The poor patency of small-caliber vascular bypass prostheses has stimulated a large body of research into alternative graft materials. This includes synthetic and, more recently, tissue-engineered hybrid products. Acceptance for international standards requires demonstration of a rigorous mechanical testing regimen, including graft strength, which has on the whole involved burst strength measurement. However, the methods used to measure burst strength have varied with respect to apparatus used and rate of graft inflation. We show that these variables lead to markedly different results. In particular, fast infusion rates may overestimate the actual burst pressure, leading to a false sense of security.

摘要

背景

由于目前可用的血管旁路移植物通畅率较低,研究人员正在致力于开发替代旁路移植物,范围从合成假体到完全生物活性移植物。美国食品药品监督管理局(FDA)等监管机构要求的测量理念以及获得欧洲合格认证(CE)标志,是要在生理预期极限之上进行测试。在临床试验能够进行之前,欧洲合格认证(CE)标志或美国食品药品监督管理局(FDA)批准需要爆破压力这一关键参数。因此,准确测量潜在多孔血管旁路移植物的爆破压力对于确保在动物体内植入及后续临床使用时具有足够强度至关重要。已经使用了多种测量爆破压力的方法。我们通过使用不同方法测试了一种新型聚氨酯基纳米复合血管假体的爆破压力,以评估所使用的方法是否会影响结果。

方法

通过注射泵以0.2、50和100 mL/min的流速将水注入由包含倍半硅氧烷的聚(碳酸酯 - 脲)聚氨酯纳米复合材料制成的带有乳胶套管内衬的多孔假体中。在最低流速下,分别在有无无孔内衬套管的情况下进行充气。使用压力传感器记录达到的峰值压力。

结果

在流速为0.2 mL/min时,使用无孔套管导致更高的爆破压力(428 mmHg对341 mmHg)。较低的流速(0.2 mL/min)产生的爆破压力低于50 mL/min(428 mmHg对451 mmHg)。在流速为50 mL/min和100 mL/min时,爆破压力未发现显著差异。

结论

使用无孔套管消除了孔隙本身带来的潜在弱点。持续的高流速始终会高估爆破压力。这些方法可能无法反映生理状态。在解释爆破压力测量方法时需要谨慎,并且在任何方法描述中都应说明流速。

临床意义

小口径血管旁路假体的通畅性差促使了对替代移植物材料的大量研究。这包括合成材料以及最近的组织工程混合产品。国际标准的认可需要证明严格的机械测试方案,包括移植物强度,总体上这涉及爆破强度测量。然而,用于测量爆破强度的方法在所用设备和移植物充气速率方面各不相同。我们表明这些变量会导致明显不同的结果。特别是,快速流速可能会高估实际爆破压力,从而产生虚假的安全感。

相似文献

1
Critical parameter of burst pressure measurement in development of bypass grafts is highly dependent on methodology used.旁路移植物开发中爆破压力测量的关键参数高度依赖于所使用的方法。
J Vasc Surg. 2006 Oct;44(4):846-52. doi: 10.1016/j.jvs.2006.07.023.
2
Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study.新型合成可选择性降解血管假体:一项初步植入研究。
J Surg Res. 2001 Feb;95(2):152-60. doi: 10.1006/jsre.2000.6042.
3
Small calibre polyhedral oligomeric silsesquioxane nanocomposite cardiovascular grafts: influence of porosity on the structure, haemocompatibility and mechanical properties.小口径多面体低聚倍半硅氧烷纳米复合材料心血管移植物:孔隙率对结构、血液相容性和机械性能的影响。
Acta Biomater. 2011 Nov;7(11):3857-67. doi: 10.1016/j.actbio.2011.06.051. Epub 2011 Jul 2.
4
[Assessment of the mechanical properties and biocompatibility of a new electrospun polyurethane vascular prosthesis].[新型电纺聚氨酯血管假体的力学性能及生物相容性评估]
Nan Fang Yi Ke Da Xue Xue Bao. 2011 Dec;31(12):2006-11.
5
Manufacture of small calibre quadruple lamina vascular bypass grafts using a novel automated extrusion-phase-inversion method and nanocomposite polymer.使用新型自动挤出相转化法和纳米复合聚合物制造小口径四层血管旁路移植物
J Biomech. 2009 Apr 16;42(6):722-30. doi: 10.1016/j.jbiomech.2009.01.003. Epub 2009 Feb 27.
6
[Effect of preparation conditions for small-diameter artificial polyurethane vascular graft on microstructure and mechanical properties].小口径人工聚氨酯血管移植物制备条件对微观结构和力学性能的影响
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2005 Jan;19(1):64-9.
7
Comparison of the direct burst pressure and the ring tensile test methods for mechanical characterization of tissue-engineered vascular substitutes.用于组织工程血管替代物力学特性表征的直接爆破压力和环拉伸试验方法的比较。
J Mech Behav Biomed Mater. 2014 Jun;34:253-63. doi: 10.1016/j.jmbbm.2014.02.017. Epub 2014 Feb 21.
8
In vitro and in vivo characterization of a silk fibroin-coated polyester vascular prosthesis.丝素蛋白涂层聚酯血管移植物的体外和体内特性研究
Artif Organs. 2008 Dec;32(12):932-41. doi: 10.1111/j.1525-1594.2008.00655.x.
9
A self-renewing, tissue-engineered vascular graft for arterial reconstruction.一种用于动脉重建的可自我更新的组织工程血管移植物。
J Thorac Cardiovasc Surg. 2008 Jul;136(1):37-45, 45.e1. doi: 10.1016/j.jtcvs.2007.06.039.
10
Randomized comparison of 6-mm straight grafts versus 6- to 8-mm tapered grafts for brachial-axillary dialysis access.用于肱动脉-腋动脉透析通路的6毫米直型移植物与6至8毫米锥形移植物的随机对照研究
J Vasc Surg. 2004 Aug;40(2):319-24. doi: 10.1016/j.jvs.2004.05.005.

引用本文的文献

1
Biomimetic Approaches in Scaffold-Based Blood Vessel Tissue Engineering.基于支架的血管组织工程中的仿生方法。
Biomimetics (Basel). 2024 Jun 22;9(7):377. doi: 10.3390/biomimetics9070377.
2
An Investigation of the Constructional Design Components Affecting the Mechanical Response and Cellular Activity of Electrospun Vascular Grafts.影响电纺血管移植物力学响应和细胞活性的结构设计组件研究
Membranes (Basel). 2022 Sep 25;12(10):929. doi: 10.3390/membranes12100929.
3
Fabrication of Highly Oriented Cylindrical Polyacrylonitrile, Poly(lactide--glycolide), Polycaprolactone and Poly(vinyl acetate) Nanofibers for Vascular Graft Applications.
用于血管移植应用的高度取向的圆柱形聚丙烯腈、聚(丙交酯-乙交酯)、聚己内酯和聚醋酸乙烯酯纳米纤维的制备
Polymers (Basel). 2021 Jun 24;13(13):2075. doi: 10.3390/polym13132075.
4
The mechanical characterization of blood vessels and their substitutes in the continuous quest for physiological-relevant performances. A critical review.对血管及其替代品进行机械特性表征,以不断追求与生理相关的性能。一篇批判性综述。
Mater Today Bio. 2021 Mar 7;10:100106. doi: 10.1016/j.mtbio.2021.100106. eCollection 2021 Mar.
5
HuBiogel incorporated fibro-porous hybrid nanomatrix graft for vascular tissue interfaces.用于血管组织界面的含HuBiogel的纤维多孔混合纳米基质移植物。
Mater Today Chem. 2020 Sep;17. doi: 10.1016/j.mtchem.2020.100323. Epub 2020 Aug 1.
6
In Vitro Evaluation of Essential Mechanical Properties and Cell Behaviors of a Novel Polylactic-co-Glycolic Acid (PLGA)-Based Tubular Scaffold for Small-Diameter Vascular Tissue Engineering.用于小直径血管组织工程的新型聚乳酸-乙醇酸共聚物(PLGA)基管状支架的基本力学性能和细胞行为的体外评估
Polymers (Basel). 2017 Jul 30;9(8):318. doi: 10.3390/polym9080318.
7
Modular Small Diameter Vascular Grafts with Bioactive Functionalities.具有生物活性功能的模块化小直径血管移植物。
PLoS One. 2015 Jul 23;10(7):e0133632. doi: 10.1371/journal.pone.0133632. eCollection 2015.
8
A potential platform for developing 3D tubular scaffolds for paediatric organ development.一种用于开发儿科器官发育三维管状支架的潜在平台。
J Mater Sci Mater Med. 2015 Mar;26(3):141. doi: 10.1007/s10856-015-5477-4. Epub 2015 Mar 4.
9
High compliance vascular grafts based on semi-interpenetrating networks.基于半互穿网络的高顺应性血管移植物。
Macromol Mater Eng. 2014 Dec;299(12):1455-1464. doi: 10.1002/mame.201400101.
10
In Vitro Study of Directly Bioprinted Perfusable Vasculature Conduits.直接生物打印可灌注血管导管的体外研究
Biomater Sci. 2015 Jan;3(1):134-43. doi: 10.1039/C4BM00234B.